Efficacy of nedocromil 2% versus fluorometholone 0.1%: A randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis

Khalid F. Tabbara, Soliman A. Al-Kharashi

Research output: Contribution to journalArticle

Abstract

Aims - To compare the efficacy of topical nedocromil 2% with fluorometholone 0.1% in vernal keratoconjunctivitis (VKC). Methods - In a double masked random design, 24 patients with severe vernal keratoconjunctivitis were placed at random on nedocromil 2% eye drops in one eye and fluorometholone 0.1% in the fellow eye. At the end of the 2 week treatment period, the patient crossed over the eye drops (if asymptomatic in one eye), or continued with nedocromil sodium in both eyes (if asymptomatic in both eyes). All patients were examined weekly and ocular surface temperature recorded for a period of 6 weeks. Results - Improvement in the watering, discharge, conjunctival hyperaemia, papillary hypertrophy, and Trantas' dots was noted in both groups, but overall fluorometholone was significantly more effective than nedocromil. Eyes treated with fluorometholone showed a significant decrease in ocular surface temperature compared with nedocromil treated eyes (p = 0.03). Conclusions - Both nedocromil and fluorometholone were effective in ameliorating the signs and symptoms of vernal keratoconjunctivitis. No adverse effects were noted in the nedocromil group.

Original languageEnglish (US)
Pages (from-to)180-184
Number of pages5
JournalBritish Journal of Ophthalmology
Volume83
Issue number2
StatePublished - 1999
Externally publishedYes

Fingerprint

Fluorometholone
Nedocromil
Allergic Conjunctivitis
Ophthalmic Solutions
Temperature
Hyperemia
Hypertrophy
Signs and Symptoms

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Efficacy of nedocromil 2% versus fluorometholone 0.1% : A randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis. / Tabbara, Khalid F.; Al-Kharashi, Soliman A.

In: British Journal of Ophthalmology, Vol. 83, No. 2, 1999, p. 180-184.

Research output: Contribution to journalArticle

@article{38f09ef8282f41d9a502f0cd651235f7,
title = "Efficacy of nedocromil 2{\%} versus fluorometholone 0.1{\%}: A randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis",
abstract = "Aims - To compare the efficacy of topical nedocromil 2{\%} with fluorometholone 0.1{\%} in vernal keratoconjunctivitis (VKC). Methods - In a double masked random design, 24 patients with severe vernal keratoconjunctivitis were placed at random on nedocromil 2{\%} eye drops in one eye and fluorometholone 0.1{\%} in the fellow eye. At the end of the 2 week treatment period, the patient crossed over the eye drops (if asymptomatic in one eye), or continued with nedocromil sodium in both eyes (if asymptomatic in both eyes). All patients were examined weekly and ocular surface temperature recorded for a period of 6 weeks. Results - Improvement in the watering, discharge, conjunctival hyperaemia, papillary hypertrophy, and Trantas' dots was noted in both groups, but overall fluorometholone was significantly more effective than nedocromil. Eyes treated with fluorometholone showed a significant decrease in ocular surface temperature compared with nedocromil treated eyes (p = 0.03). Conclusions - Both nedocromil and fluorometholone were effective in ameliorating the signs and symptoms of vernal keratoconjunctivitis. No adverse effects were noted in the nedocromil group.",
author = "Tabbara, {Khalid F.} and Al-Kharashi, {Soliman A.}",
year = "1999",
language = "English (US)",
volume = "83",
pages = "180--184",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Efficacy of nedocromil 2% versus fluorometholone 0.1%

T2 - A randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis

AU - Tabbara, Khalid F.

AU - Al-Kharashi, Soliman A.

PY - 1999

Y1 - 1999

N2 - Aims - To compare the efficacy of topical nedocromil 2% with fluorometholone 0.1% in vernal keratoconjunctivitis (VKC). Methods - In a double masked random design, 24 patients with severe vernal keratoconjunctivitis were placed at random on nedocromil 2% eye drops in one eye and fluorometholone 0.1% in the fellow eye. At the end of the 2 week treatment period, the patient crossed over the eye drops (if asymptomatic in one eye), or continued with nedocromil sodium in both eyes (if asymptomatic in both eyes). All patients were examined weekly and ocular surface temperature recorded for a period of 6 weeks. Results - Improvement in the watering, discharge, conjunctival hyperaemia, papillary hypertrophy, and Trantas' dots was noted in both groups, but overall fluorometholone was significantly more effective than nedocromil. Eyes treated with fluorometholone showed a significant decrease in ocular surface temperature compared with nedocromil treated eyes (p = 0.03). Conclusions - Both nedocromil and fluorometholone were effective in ameliorating the signs and symptoms of vernal keratoconjunctivitis. No adverse effects were noted in the nedocromil group.

AB - Aims - To compare the efficacy of topical nedocromil 2% with fluorometholone 0.1% in vernal keratoconjunctivitis (VKC). Methods - In a double masked random design, 24 patients with severe vernal keratoconjunctivitis were placed at random on nedocromil 2% eye drops in one eye and fluorometholone 0.1% in the fellow eye. At the end of the 2 week treatment period, the patient crossed over the eye drops (if asymptomatic in one eye), or continued with nedocromil sodium in both eyes (if asymptomatic in both eyes). All patients were examined weekly and ocular surface temperature recorded for a period of 6 weeks. Results - Improvement in the watering, discharge, conjunctival hyperaemia, papillary hypertrophy, and Trantas' dots was noted in both groups, but overall fluorometholone was significantly more effective than nedocromil. Eyes treated with fluorometholone showed a significant decrease in ocular surface temperature compared with nedocromil treated eyes (p = 0.03). Conclusions - Both nedocromil and fluorometholone were effective in ameliorating the signs and symptoms of vernal keratoconjunctivitis. No adverse effects were noted in the nedocromil group.

UR - http://www.scopus.com/inward/record.url?scp=0033006637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033006637&partnerID=8YFLogxK

M3 - Article

C2 - 10396195

AN - SCOPUS:0033006637

VL - 83

SP - 180

EP - 184

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 2

ER -